株探米国株
日本語 英語
エドガーで原本を確認する
FALSE000181999400018199942025-11-072025-11-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 7, 2025
ROCKET LAB CORPORATION
(Exact name of Registrant as Specified in Its Charter)
Delaware 001-39560 39-2182599
(State or Other Jurisdiction
of Incorporation)
(Commission File Number) (IRS Employer
Identification No.)
3881 McGowen Street  
Long Beach, California
  90808
(Address of Principal Executive Offices)   (Zip Code)
Registrant’s Telephone Number, Including Area Code: 714 465-5737
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
  Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.0001 per share   RKLB   The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02 Results of Operations and Financial Condition.
On November 10, 2025, Rocket Lab Corporation (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 (the “Section”) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 7, 2025, Matt Ocko notified the Company of his resignation as a member of the Company’s Board of Directors, effective November 30, 2025. Mr. Ocko’s resignation is not the result of any dispute or disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company and the Board thank Mr. Ocko for his invaluable insights, perspective, and commitment during his service on the Company’s Board.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit   Description
99.1  
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
      ROCKET LAB CORPORATION
       
Date: November 10, 2025 By: /s/ Adam Spice
      Adam Spice
Chief Financial Officer

EX-99.1 2 rklb-11102025ex991.htm EX-99.1 Document
MEDIA RELEASE
rocketlablogo.jpg
Exhibit 99.1
Rocket Lab Announces Third Quarter 2025 Financial Results, Posts Record Quarterly Revenue of $155m, Representing 48% Year-on-Year Growth at Record Gross Margins
Long Beach, California. November 10, 2025 – Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab”, “the Company”, “we,” “us,” or “our”), a global leader in launch services and space systems, today shared the financial results for fiscal third quarter ended September 30, 2025.
Rocket Lab founder and CEO, Sir Peter Beck, said: “This past quarter we’ve once again delivered record revenue of $155m at record GAAP gross margin of 37%, and a new annual launch record is just days away. With progress across our major space systems programs, record backlog of contracts for our launch services business, and well-timed, strategic M&A in growth areas that are well-aligned with next-generation defense programs like Golden Dome and the Space Development Agency’s future constellations, our momentum is strong and we’re poised to deliver long-term exciting growth.”
Business Highlights for the Third Quarter 2025, plus updates since September 30, 2025.
•Secured 17x Electron launch contracts in Q3, 2025 – a record-breaking quarter of dedicated launch contracts for our industry-leading small launch vehicle. Rocket Lab is also set to surpass its previous annual launch record in the fourth quarter, and remains on track to close out the year with 20+ launches.
•Successfully launched two back-to-back HASTE missions across the quarter at an unprecedented pace of delivery for the nation that supports critical advancements in hypersonic technology.
•Closed our acquisition of electro-optical and infrared sensor maker Geost for up to $325 million in a cash-plus-equity transaction, expanding our end-to-end capabilities for U.S. national security with launch, spacecraft, and now payloads. Other significant M&A activity for the quarter included the completed financial restructure of German laser communications company Mynaric as part of our intended acquisition process. Rocket Lab also exited the quarter with $1+ billion in liquidity following the Company’s recent at-the-market offering program, further strengthening our capital position to act decisively on our robust M&A pipeline.
•Officially opened Launch Complex 3, the test and launch site for the Company’s new medium-lift reusable rocket Neutron.
•Updating our Neutron schedule that has the rocket arriving at Rocket Lab Launch Complex 3 in Q1, 2026, with the first launch thereafter, pending the successful completion of the vehicle’s qualification testing and acceptance program.
rocketlabcorp.com | media@rocketlabusa.com

MEDIA RELEASE
rocketlablogo.jpg

Fourth Quarter 2025 Guidance
For the fourth quarter of 2025, Rocket Lab expects:
•Revenue between $170 million and $180 million.
•GAAP Gross Margins between 37% and 39%.
•Non-GAAP Gross Margins between 43% and 45%.
•GAAP Operating Expenses between $122 million and $128 million.
•Non-GAAP Operating Expenses between $107 million and $113 million.
•Expected Interest Income, net $3.5 million.
•Adjusted EBITDA loss of $23 million and $29 million.
•Basic Weighted Average Common Shares Outstanding of 571 million, including approximately 46 million of Series A Convertible Participating Preferred Shares.
See “Use of Non-GAAP Financial Measures” below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q4 2025 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $15 million to $17 million in Q4 2025.
Conference Call Information
Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our third quarter, to provide our outlook for the fourth quarter, and other updates.
The live webcast and a replay of the webcast will be available on Rocket Lab’s Investor Relations website: https://investors.rocketlabcorp.com/
Rocket Lab Investor Relations Contact
Patrick Vorenkamp
investors@rocketlabusa.com
Rocket Lab Media Contact
Murielle Baker
media@rocketlabusa.com
About Rocket Lab
Rocket Lab is a leading space company that provides launch services, spacecraft, payloads and satellite components serving commercial, government, and national security markets. Rocket Lab’s Electron rocket is the world’s most frequently launched orbital small rocket; its HASTE rocket provides hypersonic test launch capability for the U.S. government and allied nations; and its Neutron launch vehicle in development will unlock medium launch for constellation deployment, national security and exploration missions. Rocket Lab’s spacecraft and satellite components have enabled more than 1,700 missions spanning commercial, defense and national security missions including GPS, constellations, and exploration missions to the Moon, Mars, and Venus. Rocket Lab is a publicly listed company on the Nasdaq stock exchange (RKLB). Learn more at www.rocketlabcorp.com.
rocketlabcorp.com | media@rocketlabusa.com

MEDIA RELEASE
rocketlablogo.jpg
FORWARD LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of financial results for the first quarter of 2025, launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development and anticipated timeline to launch, operational expansion and business strategy are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.investors.rocketlabcorp.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
USE OF NON-GAAP FINANCIAL MEASURES
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America (“GAAP”) with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:
ADJUSTED EBITDA
EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.
OTHER NON-GAAP FINANCIAL MEASURES
Non-GAAP gross profit, gross margin, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.
rocketlabcorp.com | media@rocketlabusa.com

MEDIA RELEASE
rocketlablogo.jpg
ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024
(unaudited; in thousands, except share and per share data)
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
Revenues:
Product revenues $ 104,042  $ 79,419  $ 277,571  $ 205,848 
Service revenues 51,038  25,389  144,576  97,978 
Total revenues 155,080  104,808  422,147  303,826 
Cost of revenues:
Cost of product revenues 72,841  58,448  188,402  153,215 
Cost of service revenues 24,925  18,364  94,796  71,279 
Total cost of revenues 97,766  76,812  283,198  224,494 
Gross profit 57,314  27,996  138,949  79,332 
Operating expenses:
Research and development, net 70,694  47,723  191,937  126,139 
Selling, general and administrative 45,589  32,172  124,808  91,445 
Total operating expenses 116,283  79,895  316,745  217,584 
Operating loss (58,969) (51,899) (177,796) (138,252)
Other income (expense):
Interest expense, net (590) (454) (5,547) (2,176)
Gain (loss) on foreign exchange 388  (490) (235) (465)
Other (expense) income, net (177) 1,848  (675) 3,152 
Total other (expense) income, net (379) 904  (6,457) 511 
Loss before income taxes (59,348) (50,995) (184,253) (137,741)
Benefit (provision) for income taxes 41,091  (944) 38,966  (89)
Net loss $ (18,257) $ (51,939) $ (145,287) $ (137,830)
Net loss per share attributable to Rocket Lab Corporation:
Basic and diluted $ (0.03) $ (0.10) $ (0.28) $ (0.28)
Weighted-average common shares outstanding:
Basic and diluted 528,725,980 497,701,715 516,560,266 493,976,025
rocketlabcorp.com | media@rocketlabusa.com

MEDIA RELEASE
rocketlablogo.jpg
ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024
(unaudited; in thousands, except share and per share values)
September 30, 2025
(unaudited)
December 31, 2024
Assets
Current assets:
Cash and cash equivalents $ 807,875  $ 271,042 
Marketable securities, current 168,865  147,948 
Accounts receivable, net 59,086  36,440 
Contract assets 52,785  63,108 
Inventories 144,999  119,074 
Prepaids and other current assets 82,813  55,009 
Total current assets 1,316,423  692,621 
Non-current assets:
Property, plant and equipment, net 278,003  194,838 
Intangible assets, net 231,984  58,637 
Goodwill 217,709  71,020 
Right-of-use assets - operating leases 90,844  53,664 
Right-of-use assets - finance leases 14,022  14,396 
Marketable securities, non-current 46,202  60,686 
Restricted cash 4,835  4,260 
Deferred income tax assets, net —  3,010 
Other non-current assets 21,373  31,210 
Total assets $ 2,221,395  $ 1,184,342 
Liabilities and Stockholders’ Equity
Current liabilities:
Trade payables $ 61,229  $ 53,059 
Accrued expenses 17,961  19,460 
Employee benefits payable 82,174  20,847 
Contract liabilities 208,243  216,160 
Current installments of long-term borrowings 17,090  12,045 
Other current liabilities 27,760  17,954 
Total current liabilities 414,457  339,525 
Non-current liabilities:
Convertible senior notes, net 347,014  345,392 
Long-term borrowings, net, excluding current installments 51,267  44,049 
Non-current operating lease liabilities 86,505  51,965 
Non-current finance lease liabilities 14,742  14,970 
Deferred tax liabilities 3,007  891 
Other non-current liabilities 23,417  5,097 
Total liabilities 940,409  801,889 
COMMITMENTS AND CONTINGENCIES
Stockholders’ equity:
Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 45,951,250 and 0 at September 30, 2025 and December 31, 2024, respectively — 
Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 542,175,866 and 504,453,785 at September 30, 2025 and December 31, 2024, respectively; outstanding shares: 496,224,616 and 504,453,785 at September 30, 2025 and December 31, 2024, respectively 50  50 
Treasury stock, at cost; shares: 45,951,250 and 0 at September 30, 2025 and December 31, 2024, respectively —  — 
Additional paid-in capital 2,241,982  1,198,909 
Accumulated deficit (958,988) (813,701)
Accumulated other comprehensive loss (2,063) (2,805)
Total stockholders’ equity 1,280,986  382,453 
Total liabilities and stockholders’ equity $ 2,221,395  $ 1,184,342 
rocketlabcorp.com | media@rocketlabusa.com

MEDIA RELEASE
rocketlablogo.jpg
ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024
(unaudited; in thousands)
For the Nine Months Ended September 30,
2025 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (145,287) $ (137,830)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 29,191  24,516 
Stock-based compensation expense 52,894  39,944 
Loss (gain) on disposal of assets 2,356  (2,356)
Loss on extinguishment of long-term debt —  1,330 
Amortization of debt issuance costs and discount 2,551  2,272 
Noncash lease expense 5,975  4,437 
Change in the fair value of contingent consideration —  (218)
Accretion of marketable securities purchased at a discount (1,599) (2,272)
Deferred income taxes (33,049) 2,310 
Changes in operating assets and liabilities:
Accounts receivable, net (19,442) 12,928 
Contract assets 12,608  (36,510)
Inventories (25,567) (7,118)
Prepaids and other current assets (17,455) 1,951 
Other non-current assets 10,132  544 
Trade payables (1,634) 13,853 
Accrued expenses 2,671  2,980 
Employee benefits payables 43,417  3,525 
Contract liabilities (9,187) 27,791 
Other current liabilities (1,358) 4,088 
Non-current lease liabilities (8,269) (4,321)
Other non-current liabilities 62  1,653 
Net cash used in operating activities (100,990) (46,503)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, equipment and software (106,631) (45,539)
Proceeds on disposal of assets, net     397  11,756 
Cash paid for business combination, net of acquired cash (132,441) — 
Purchases of marketable securities (187,780) (149,548)
Maturities of marketable securities 179,822  102,930 
Sale of marketable securities 3,383  — 
Net cash used in investing activities (243,250) (80,401)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from ATM Equity Offerings
865,453  — 
Issuance costs related to ATM Equity Offerings (20,134) — 
Proceeds from the exercise of stock options 2,539  2,074 
Proceeds from Employee Stock Purchase Plan 7,751  4,098 
Proceeds from sale of employees restricted stock units to cover taxes 80,659  14,991 
Minimum tax withholding paid on behalf of employees for restricted stock units (65,672) (15,169)
Purchase of capped calls related to issuance of convertible senior notes —  (43,168)
Proceeds from issuance of convertible senior notes —  355,000 
Proceeds from secured term loans
26,716  — 
Repayments on secured term loan (15,103) (48,853)
Payment of debt issuance costs (278) (12,205)
Finance lease principal payments (197) (269)
Net cash provided by financing activities 881,734  256,499 
Effect of exchange rate changes on cash and cash equivalents (86) 763 
Net increase in cash and cash equivalents and restricted cash 537,408  130,358 
Cash and cash equivalents, and restricted cash, beginning of period 275,302  166,434 
Cash and cash equivalents, and restricted cash, end of period $ 812,710  $ 296,792 
rocketlabcorp.com | media@rocketlabusa.com

MEDIA RELEASE
rocketlablogo.jpg
ROCKET LAB CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024
(unaudited; in thousands)
The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
NET LOSS $ (18,257) $ (51,939) $ (145,287) $ (137,830)
Depreciation 6,490  4,793  18,061  14,513 
Amortization 5,236  3,302  11,130  10,003 
Stock-based compensation expense 15,727  12,896  52,894  39,944 
Transaction costs 5,118  23  11,504  407 
Interest expense, net 590  454  5,547  2,176 
Change in fair value of contingent consideration —  —  —  (218)
(Benefit) provision for income taxes (41,091) 944  (38,966) 89 
(Gain) loss on foreign exchange (388) 490  235  465 
Accretion of marketable securities and cash equivalents purchased at a discount (553) (666) (1,810) (2,272)
Loss (gain) on disposal of assets 853  (1,164) 2,356  (2,356)
Employee retention credit —  —  515  — 
Loss on extinguishment of debt —  —  —  1,330 
ADJUSTED EBITDA $ (26,275) $ (30,867) $ (83,821) $ (73,749)
rocketlabcorp.com | media@rocketlabusa.com

MEDIA RELEASE
rocketlablogo.jpg
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
GAAP Gross profit $ 57,314  $ 27,996  $ 138,949  $ 79,332 
Stock-based compensation 3,539  3,029  12,351  10,205 
Amortization of purchased intangibles and favorable lease 4,126  1,763  7,772  5,247 
Employee retention credit —  —  278  — 
Non-GAAP Gross profit $ 64,979  $ 32,788  $ 159,350  $ 94,784 
Non-GAAP Gross margin 41.9  % 31.3  % 37.7  % 31.2  %
 
GAAP Research and development, net $ 70,694  $ 47,723  $ 191,937  $ 126,139 
Stock-based compensation (5,588) (4,626) (16,055) (13,660)
Amortization of purchased intangibles and favorable lease —  (302) (329) (686)
Employee retention credit —  —  (88) — 
Non-GAAP Research and development, net $ 65,106  $ 42,795  $ 175,465  $ 111,793 
 
GAAP Selling, general and administrative $ 45,589  $ 32,172  $ 124,808  $ 91,445 
Stock-based compensation (6,600) (5,241) (24,488) (16,079)
Amortization of purchased intangibles and favorable lease (846) (960) (2,250) (3,274)
Transaction costs (5,118) (23) (11,504) (407)
Change in fair value of contingent consideration —  —  —  218 
Employee retention credit —  —  (149) — 
Non-GAAP Selling, general and administrative $ 33,025  $ 25,948  $ 86,417  $ 71,903 
 
GAAP Operating expenses $ 116,283  $ 79,895  $ 316,745  $ 217,584 
Stock-based compensation (12,188) (9,867) (40,543) (29,739)
Amortization of purchased intangibles and favorable lease (846) (1,262) (2,579) (3,960)
Transaction costs (5,118) (23) (11,504) (407)
Change in fair value of contingent consideration —  —  —  218 
Employee retention credit —  —  (237) — 
Non-GAAP Operating expenses $ 98,131  $ 68,743  $ 261,882  $ 183,696 
 
GAAP Operating loss $ (58,969) $ (51,899) $ (177,796) $ (138,252)
Total non-GAAP adjustments 25,817  15,944  75,264  49,340 
Non-GAAP Operating loss $ (33,152) $ (35,955) $ (102,532) $ (88,912)
 
GAAP Total other (expense) income, net $ (379) $ 904  $ (6,457) $ 511 
(Gain) loss on foreign exchange (388) 490  235  465 
Loss (gain) on disposal of assets 853  (1,164) 2,356  (2,356)
Loss on extinguishment of debt —  —  —  1,330 
Non-GAAP Total other income (expense), net $ 86  $ 230  $ (3,866) $ (50)
rocketlabcorp.com | media@rocketlabusa.com